Genotypes of MDR1 gene polymorphism and drug therapy of benign prostate hyperplasia

Мавлянов, И, Мавлянов, З, Рахматов, А, Мавлянов, И, Мавлянов, З, Рахматов, А, Mavlyanov, I, Mavlyanov, Z, Rakhmatov, A

Тиббиёт ва спорт · 2026-yil

Annotatsiya

The article studies the effectiveness of treatment with the use of Prostamed and Permixon in patients with benign prostatic hyperplasia in terms of genotypes of MDR1 gene polymorphism, which is a genetic determinant of glycoprotein R protein. The results showed that there was a correlation between G2677T genotype variants of MDR1 gene and T3435C genotype variants with treatment efficacy.

Maqola ma’lumotlari
MualliflarМавлянов, И, Мавлянов, З, Рахматов, А, Мавлянов, И, Мавлянов, З, Рахматов, А, Mavlyanov, I, Mavlyanov, Z, Rakhmatov, A
JurnalТиббиёт ва спорт
NashriyotЎзбекистон Миллий олимпия қўмитаси хузуридаги, Республика спорт тиббиёти илмий-амалий маркази
ISSN2181-998X
Nashr sanasi2026-06-10
Son2
Betlar71-73
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-27

Maqolaning asl sahifasi

Kalit so‘zlar

доброкачественная гиперплазия предстательной железы (ДГПЖ), ген MDR1, полиморфизмы гена MDR1 G2677T и T3435C, Простамед, Пермиксон, IPSS, QOL, Vprostata, Qmax, R остаточной мочи, ПСА, benign prostatic hyperplasia (BPH), MDR1 gene, MDR1 gene G2677T and T3435C polymorphisms, Prostamed, Permixon, IPSS, QOL, Vprostata, Qmax, R residual urine, PSA, простата бези ҳавфсиз гиперплазияси (ПБХГ), MDR1 гени, MDR1 гени G2677T ва T3435C полиморфизмлари, Простамед, Пермиксон, IPSS, QOL, Vпростата, Qmax, R қолдиқ сийдик, PSA

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APAМавлянов, И, Мавлянов, З, Рахматов, А, Мавлянов, И, Мавлянов, З, Рахматов, А, Mavlyanov, I, Mavlyanov, Z, & Rakhmatov, A (2026). GENOTYPES OF MDR1 GENE POLYMORPHISM AND DRUG THERAPY OF BENIGN PROSTATE HYPERPLASIA. Тиббиёт ва спорт, (2), 71-73. https://journal.sportmed.uz/index.php/medsport/article/view/90
GOST (OAK)Мавлянов, И va b. GENOTYPES OF MDR1 GENE POLYMORPHISM AND DRUG THERAPY OF BENIGN PROSTATE HYPERPLASIA // Тиббиёт ва спорт. – 2026. – № 2. – P. 71-73.
MLAМавлянов, И, Мавлянов, З, Рахматов, А, Мавлянов, И, Мавлянов, З, Рахматов, А, Mavlyanov, I, Mavlyanov, Z, and Rakhmatov, A. “GENOTYPES OF MDR1 GENE POLYMORPHISM AND DRUG THERAPY OF BENIGN PROSTATE HYPERPLASIA.” Тиббиёт ва спорт, (2), 71-73, 2026. https://journal.sportmed.uz/index.php/medsport/article/view/90
ChicagoМавлянов, И, Мавлянов, З, Рахматов, А, Мавлянов, И, Мавлянов, З, Рахматов, А, Mavlyanov, I, Mavlyanov, Z, and Rakhmatov, A. “GENOTYPES OF MDR1 GENE POLYMORPHISM AND DRUG THERAPY OF BENIGN PROSTATE HYPERPLASIA.” Тиббиёт ва спорт, (2), 71-73 (2026). https://journal.sportmed.uz/index.php/medsport/article/view/90
HarvardМавлянов, И, Мавлянов, З, Рахматов, А, Мавлянов, И, Мавлянов, З, Рахматов, А, Mavlyanov, I, Mavlyanov, Z, and Rakhmatov, A (2026) ‘GENOTYPES OF MDR1 GENE POLYMORPHISM AND DRUG THERAPY OF BENIGN PROSTATE HYPERPLASIA’, Тиббиёт ва спорт, (2), 71-73. https://journal.sportmed.uz/index.php/medsport/article/view/90
BibTeX
@article{article2026,
  title = {GENOTYPES OF MDR1 GENE POLYMORPHISM AND DRUG THERAPY OF BENIGN PROSTATE HYPERPLASIA},
  author = {Мавлянов, И and Мавлянов, З and Рахматов, А and Мавлянов, И and Мавлянов, З and Рахматов, А and Mavlyanov, I and Mavlyanov, Z and Rakhmatov, A},
  journal = {Тиббиёт ва спорт},
  year = {2026},
  number = {2},
  pages = {71-73},
  url = {https://journal.sportmed.uz/index.php/medsport/article/view/90}
}

Boshqa maqola uchun iqtibos tayyorlash

Тиббиёт ва спорт jurnalidan boshqa maqolalar

Тиббиёт ва спорт — barcha maqolalar · 2026-yil arxivi

Мавлянов, И — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari